KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Change in Taxes (2016 - 2025)

Globus Medical (GMED) has disclosed Change in Taxes for 15 consecutive years, with $7.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Taxes rose 183.34% year-over-year to $7.1 million, compared with a TTM value of -$50.9 million through Dec 2025, down 280.14%, and an annual FY2025 reading of -$50.9 million, down 280.14% over the prior year.
  • Change in Taxes was $7.1 million for Q4 2025 at Globus Medical, up from -$19.3 million in the prior quarter.
  • Across five years, Change in Taxes topped out at $40.5 million in Q1 2024 and bottomed at -$58.2 million in Q2 2025.
  • Average Change in Taxes over 5 years is -$3.1 million, with a median of -$741500.0 recorded in 2021.
  • Peak annual rise in Change in Taxes hit 753.41% in 2021, while the deepest fall reached 697.74% in 2021.
  • Year by year, Change in Taxes stood at $15.0 million in 2021, then plummeted by 114.48% to -$2.2 million in 2022, then tumbled by 533.62% to -$13.8 million in 2023, then surged by 38.37% to -$8.5 million in 2024, then surged by 183.34% to $7.1 million in 2025.
  • Business Quant data shows Change in Taxes for GMED at $7.1 million in Q4 2025, -$19.3 million in Q3 2025, and -$58.2 million in Q2 2025.